Explainer

Is Depression Treatable? What Trials Show About Success Rates

Yes. The APA says 70% to 90% of people with depression eventually respond. In trials, 41% responded to therapy in two months vs 17% with usual care.

Mental Health Stats Research Team 6 min read

Key Takeaways

  • Depression is treatable: WHO's 2026 fact sheet states that effective treatment exists for mild, moderate and severe depression[1].Yes[1]
  • The American Psychiatric Association says 70% to 90% of people with depression eventually respond well to treatment, often after more than one attempt[2].70-90%[2]
  • Across 228 trials, 41% of people in psychotherapy responded within about two months, compared with 17% in usual care[3].41%[3]
  • In 232 placebo-controlled trials submitted to the FDA, 24.5% of people on an antidepressant had a large improvement, compared with 9.6% on placebo[4].24.5%[4]
  • In 2025, 65.9% of U.S. adults with a past-year major depressive episode received mental health treatment, and about one third received none[5].65.9%[5]
  • Worldwide, only 9.1% of people with major depressive disorder received minimally adequate treatment in 2021[6].9.1%[6]

Is Depression Treatable? Yes, at Every Level of Severity

Is depression treatable? Yes. The World Health Organization's 2026 fact sheet states that there is effective treatment for mild, moderate and severe depression, with psychological treatments and antidepressant medicines as the core options[1].

The American Psychiatric Association calls depression among the most treatable of mental disorders and says that between 70% and 90% of people with depression eventually respond well to treatment[2]. The word "eventually" matters: the figure describes response over the course of care, not the odds that a first treatment works.

Treatable is not the same as curable. Treatment aims for response and remission, and episodes can return; long-term recovery and recurrence data are covered in Is Depression Curable?.

Response and remission

In depression trials, response usually means at least a 50% reduction in symptom scores from the start of treatment, and remission means scoring below a low cutoff, such as under 7 on the Hamilton Depression Rating Scale[3].

Remission is the stricter outcome. A person can respond to treatment and still have symptoms.

Related Terms

treatment response
remission
Hamilton Depression Rating Scale (HAM-D)
placebo response

Source: Cuijpers et al., Acta Psychiatrica Scandinavica, 2021

What Is the Success Rate of Depression Treatment?

Trial data put numbers on that broad estimate. A 2021 meta-analysis of 228 randomized trials found that 41% of people in psychotherapy responded at about two months, compared with 17% in usual care, 16% on a waitlist and 31% on pill placebo[3].

For medication, an FDA analysis of 232 placebo-controlled trials with 73,388 participants found that 24.5% of people taking an antidepressant had a large improvement, compared with 9.6% of people on placebo[4]. The authors estimated that about 15% of participants have a substantial benefit from the drug beyond the placebo effect[4].

Average scores tell a similar story. Hamilton scores improved by 9.8 points on an antidepressant and 8.0 points on placebo, a mean difference of 1.75 points[4].

The two findings point the same way. Many people improve with any structured care, including placebo, and active treatment raises the share who improve substantially.

Repeated attempts close more of the gap. In the NIMH-funded STAR*D study, about one third of participants reached remission on the first medication, and another 10% to 15% responded without reaching remission[7]. Across four treatment levels, almost 70% of those who did not withdraw became symptom-free[7].

That cumulative figure has a caveat: withdrawal rose at each step, from 21% after level 1 to 30% after level 2 and 42% after level 3[7]. A step-by-step reading of STAR*D and its reanalysis is in How Is Depression Cured?.

Share of People Who Improved, by Treatment and Comparison Group

OutcomeGroupShare
Response at about 2 monthsPsychotherapy41%
Response at about 2 monthsPill placebo31%
Response at about 2 monthsUsual care17%
Response at about 2 monthsWaitlist16%
Large improvementAntidepressant24.5%
Large improvementPlacebo9.6%
Remission, first medication (STAR*D)MedicationAbout 33%
Remission after up to 4 steps (STAR*D)Those who stayed in the studyAlmost 70%
Remission within 12 monthsUntreated adults in primary care53%

Improvement rates for depression by treatment and comparison group, from trial meta-analyses (2021, 2022), the STAR*D study and a 2013 meta-analysis of untreated depression[3][4][7][8].

1Response means at least a 50% reduction in symptoms[3].

2Large improvement is the highest of three response groups found in FDA trial data, with a mean gain of 16 points on the Hamilton scale[4].

3Definitions and time frames differ across studies, so rows are not directly comparable.

Sources

  • •Cuijpers et al., 2021
  • •Stone et al., BMJ, 2022
  • •NIMH STAR*D
  • •Whiteford et al., 2013
People with depression who responded to psychotherapy within about two months, across 228 randomized trials
41%

That compares with 17% in usual care and 31% on pill placebo. Response means at least a 50% drop in symptom scores.

"an overall response rate of 0.41"

Acta Psychiatrica Scandinavica (Cuijpers et al.)(2021) View Source
How these numbers are measured: Trial response rates come from volunteers who met each study's entry criteria and were followed for weeks to months. They describe symptom change on rating scales, not long-term recovery, and they can differ from results in routine care.

Is Severe Depression Treatable?

Yes, and the added benefit of medication appears largest in severe cases. A 2010 JAMA patient-level analysis of 6 trials with 718 patients found the drug-placebo difference was small (Cohen's d under 0.20) when Hamilton scores were below 23, and reached the threshold for clinical significance at a baseline score of 25[9].

The 2022 FDA analysis likewise found that differences between drug and placebo grew with baseline severity[4]. WHO guidance follows the same pattern: antidepressants are not needed for mild depression and can be combined with psychological treatment in moderate and severe depression[1].

For severe episodes that have not responded to other treatments, the APA describes electroconvulsive therapy (ECT) as a mainstream rather than last-resort treatment, typically given two to three times a week for six to 12 treatments[2]. Trial results for brain stimulation are covered in ECT: How It Works and What Studies Show and TMS Treatment for Depression.

Can Depression Be Treated Without Medication?

Yes. WHO lists psychological treatments as the first treatments for depression and names behavioral activation, cognitive behavioral therapy, interpersonal psychotherapy and problem-solving therapy as effective options[1]. These can be delivered in person, online, by supervised lay therapists, or through self-help manuals, websites and apps[1].

The 41% response rate in the 2021 meta-analysis comes entirely from psychotherapy, with no medication involved[3]. The APA describes cognitive behavioral therapy as one of the most common forms of psychotherapy[2]; its trial record is covered in Cognitive Behavioral Therapy for Depression.

Exercise has also been tested as a treatment. A 2024 BMJ network meta-analysis of 218 studies with 14,170 participants found moderate reductions in depression for walking or jogging, yoga and strength training compared with active controls such as usual care[10].

The authors rated confidence in those results as low for walking or jogging and very low for other exercise types, because only one study met Cochrane criteria for low risk of bias[10]. Benefits rose with the intensity prescribed, and strength training and yoga were the best tolerated[10].

Age changes the options. WHO advises that antidepressants should not be used to treat depression in children and are not the first-line treatment in adolescents, among whom they should be used with extra caution[1].

How Long Does Depression Treatment Take to Work?

According to the APA, antidepressants may produce some improvement within the first week or two, but full benefits may not appear for two to three months[2]. In psychotherapy, significant improvement can often be made in 10 to 15 sessions, depending on severity[2].

In STAR*D, participants on the first medication took an average of six weeks to reach response and nearly seven weeks to reach remission[7].

Improvement is not the end point. The APA reports that psychiatrists usually recommend continuing medication for six or more months after symptoms improve, with longer maintenance for people who have had multiple episodes or have a strong family history of depression[2].

Does Depression Go Away Without Treatment?

Sometimes. A 2013 meta-analysis of 19 studies estimated that among untreated adults in primary care, 23% of depression cases remit within 3 months, 32% within 6 months and 53% within 12 months[8].

The authors noted that their samples likely over-represented mild-to-moderate depression and that the estimates may not apply to more severe depression[8]. Waitlist groups in psychotherapy trials, which are also untreated, had a 16% response rate at about two months, although that outcome is measured differently[3].

What Happens When the First Treatment Does Not Work?

A first treatment that fails does not make depression untreatable. In STAR*D, about 25% of participants who switched medications at level 2 became symptom-free, as did about one third of those who added a second medication[7].

Remission rates fell at later steps, to 12% to 20% for level 3 switches and 7% to 10% at level 4[7]. Depression that does not improve after several adequate attempts is often called treatment-resistant depression, and NIMH supports research on therapies for people who do not improve after trying multiple treatment options[11].

Medication strategies after a first antidepressant, including switching and adding drugs, are compared in Anti-Depression Meds: Drug Classes, Trial Results, Side Effects.

Why Many People With Treatable Depression Go Untreated

In the U.S., 19.7 million adults had a major depressive episode in 2025, and 65.9% of them received some form of mental health treatment that year, according to the National Survey on Drug Use and Health[5]. About one third received no mental health treatment at all[5].

Young adults were the least likely to be treated: 59.1% of 18- to 25-year-olds with a past-year episode received treatment, compared with 68.6% of adults aged 26 to 49 and 67.6% of adults 50 or older[5]. Among adults with an episode, 51.7% took prescription medication for their mental health, 47.6% received outpatient care and 44.7% used telehealth[5].

Adolescents had a wider gap. Of the 3.7 million 12- to 17-year-olds with a past-year major depressive episode in 2025, 57.7% received mental health treatment and 42.3% did not[5].

Receiving any treatment is a lower bar than receiving adequate treatment. A 2024 Lancet Psychiatry analysis estimated that 9.1% of people with major depressive disorder worldwide received minimally adequate treatment in 2021, defined as one month of medication plus four doctor visits, or eight psychotherapy visits[6].

Coverage reached 27.0% in high-income locations and fell to 2.0% in sub-Saharan Africa[6]. WHO attributes the gap to underinvestment in mental health care, a shortage of trained providers and stigma[1].

Frequently Asked Questions

Sources & References

  1. World Health Organization. Depressive disorder (depression). World Health Organization. Published 2026. Accessed October 2026. https://www.who.int/news-room/fact-sheets/detail/depression [Link]
  2. American Psychiatric Association. What Is Depression? American Psychiatric Association. Published 2024. Accessed October 2026. https://www.psychiatry.org/patients-families/depression/what-is-depression [Link]
  3. Cuijpers P, Karyotaki E, Ciharova M, et al. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: a meta-analysis. Acta Psychiatrica Scandinavica. Published 2021. Accessed October 2026. https://doi.org/10.1111/acps.13335 [Link]
  4. Stone MB, Yaseen ZS, Miller BJ, et al. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. BMJ. Published 2022. Accessed October 2026. https://www.bmj.com/content/378/bmj-2021-067606 [Link]
  5. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2025 National Survey on Drug Use and Health. SAMHSA. Published 2026. Accessed October 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt57150/2025-nsduh-annual-national-html/2025-nsduh-annual-national.htm [Link]
  6. Santomauro DF, Vos T, Whiteford HA, et al. Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021. The Lancet Psychiatry. Published 2024. Accessed October 2026. https://doi.org/10.1016/S2215-0366(24)00317-1 [Link]
  7. National Institute of Mental Health. Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study: All Medication Levels. National Institutes of Health. Accessed October 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/stard/allmedicationlevels [Link]
  8. Whiteford HA, Harris MG, McKeon G, et al. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological Medicine. Published 2013. Accessed October 2026. https://doi.org/10.1017/S0033291712001717 [Link]
  9. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. Published 2010. Accessed October 2026. https://jamanetwork.com/journals/jama/fullarticle/185157 [Link]
  10. Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. Published 2024. Accessed October 2026. https://www.bmj.com/content/384/bmj-2023-075847 [Link]
  11. National Institute of Mental Health. Depression. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/depression [Link]

Related Statistics